Trend analysis of smoking-attributable hospitalizations in Thailand, 2007–2014
More details
Hide details
Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Roengrudee Patanavanich   

Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 207 Rama VI Road, Ratchathewi District, 10400 Bangkok, Thailand
Publish date: 2018-11-05
Tob. Induc. Dis. 2018;16(November):52
Tobacco use is a major preventable risk factor for many noncommunicable diseases. Smoking-attributable mortality has been well described. However, the prevalence of smoking-attributable hospitalization (SAH) and associated costs have been less documented, especially in low- and middle-income countries. Our objective was to estimate the number of hospital admissions and expenditure attributable to tobacco use during 2007–2014 in Thailand.

Hospitalization data between 2007 and 2014 were used for the analysis. SAHs were derived by applying smoking-attributable fractions, based on Thailand’s estimates of smoking prevalence data and relative risks extracted from the published literature, to hospital admissions related to smoking according to the International Classification of Diseases version 10. Age-adjusted SAHs among adults age 35 and older were calculated. Joinpoint regression analysis was used to detect changes in trends among genders and geographical areas, based on annual per cent change (APC) and average annual per cent change (AAPC). Costs related to SAHs were also estimated.

During 2007–2014, among adults age 35 years and older, smoking accounted for almost 3.6 million hospital admissions, with attributable hospital costs calculated at more than US$572 million annually, which represents 16.8% of the national hospital budget. While the age-adjusted rate of SAHs had been relatively stable (AAPC=1.12), the age-adjusted rate of SAHs due to cancers increased significantly for both sexes (AAPC=2.33). Cardiovascular diseases related to smoking increased significantly among men (AAPC=2.5), whereas, COPD, the most common smoking-related conditions decreased significantly during 2011–2014 (APC= -7.21). Furthermore, more provinces in the northeastern and the southern regions where smoking prevalence was higher than the national average have a significantly higher AAPC of SAH than other parts of the country.

Smoking remains a significant health and economic burden in Thailand. Findings from this study pose compelling evidence for Thailand to advance tobacco control efforts to reduce the financial and social burden of diseases attributable to smoking.

U.S. Department of Health and Human Services. The health consequences of smoking: 50 years of progress: A report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
World Health Organization. WHO global report on trends in prevalence of tobacco smoking 2000-2025. 2nd ed. Geneva, Switzerland: World Health Organization; 2018.
World Health Organization. World No Tobacco Day 2018: Tobacco breaks hearts – Choose health, not tobacco. Geneva, Switzerland: World Health Organization; 2018.
Vatheesatogkit P, Termsirikulchai L, Haman S, et al. Status of tobacco use and its control: Thailand report card. Bangkok, Thailand: Southeast Asia Tobacco Control Alliance; 2008.
National Statistical Office. Smoking situation in Thailand. Published May, 2007. Accessed July 29, 2018.
Pitayarangsarit S, Pankrajang P. Statistics report on tobacco consumption in Thailand, 2018. Bangkok, Thailand: Tobacco Control Research and Knowledge Management Center; July 2018.
Tu AW, Buxton JA, Stockwell T. Estimates of smoking-attributable mortality and hospitalization in BC, 2002-2007. Can J Public Health. 2012;103(2):137-141.
Pircher SLM, Li SQ, Guthridge SL. Trend analysis of hospital admissions attributable to tobacco smoking, northern territory aboriginal and non-aboriginal populations, 1998 to 2009. BMC Public Health. 2012;12:545. doi:10.1186/1471-2458-12-545
Baliunas D, Patra J, Rehm J, Popova S, Taylor B. Smoking-attributable morbidity: acute care hospital diagnoses and days of treatment in Canada, 2002. BMC Public Health. 2007;7:247. doi:10.1186/1471-2458-7-247
National Statistical Office. The smoking and drinking behavioral survey 2011. Bangkok, Thailand: Ministry of Information and Communication Technology, National Statistical Office, Statistical Forecasting Bureau; 2012.
National Health Security Office. NHSO annual report fiscal year 2015. Bangkok, Thailand: National Health Security Office; 2016.
Official Statistics Registration Systems. Statistics download: Population by ages. Accessed May 4, 2018.
World Health Organization. World standard population. Accessed May 5, 2018.
Levin ML. The occurrence of lung cancer in man. Acta Unio Contra Cancrum. 1953;9:531-541.
Hanley JA. A Heuristic Approach to the formulas for population attributable fraction. J Epidemiol Community Health. 2001;55:508-514. doi:10.1136/jech.55.7.508
Fone D, Morgan J, Fry R, et al. Change in alcohol outlet density and alcohol-related harm to population health (chalice): A comprehensive record-linked database study in Wales. Public Health Research. 2016;4(3). doi:10.3310/phr04030
Riewpaiboon A. Standard cost lists for health economic evaluation in Thailand. J Med Assoc Thai. 2014;97(Suppl. 5):S127-S134.
Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Statistics in Medicine. 2009;28:3670-3682. doi:10.1002/sim.3733
National Cancer Institute. Joinpoint regression program, 2018. https://surveillance.cancer.go.... Accessed July 16, 2018.
GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: A systematic analysis from the global burden of disease study 2015. Lancet. 2017;389:1885-1906.
National Health Service. Statistic on smoking England: 2017. Accessed July 29, 2018.
Weiss W. Cigarette Smoking and lung cancer trends: A light at the end of the tunnel? Chest. 1997;111(5):1414-1416. doi:10.1378/chest.111.5.1414
Wong KY, Seow A, Koh WP, Shankar A, Lee HP, Yu MC. Smoking cessation and lung cancer risk in an asian population: findings from the Singapore Chinese health study. British Journal of Cancer. 2010;103:1093-1096. doi:10.1038/sj.bjc.6605782
Lee PN, Fry JS, Forey BA. Estimating the decline in excess risk of chronic obstructive pulmonary disease following quitting smoking-a systematic review based on the negative exponential model. Regulatory Toxicology and Pharmacology. 2014;68:231-239. doi:10.1016/j.yrtph.2013.12.006
Liu Y, Pleasants RA, Croft JB, et al. Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history. Int J Chron Obstruct Pulmon Dis. 2015;10:1409-1416. doi:10.2147/copd.s82259
American Cancer Society. Benefit of quitting smoking over time. Accesed July 28, 2018.
Lopez AD, Collishaw NE, Piha T. A descriptive model of the cigarette epidemic in developed countries. Tob Control. 1994;3:242-247. doi:10.1136/tc.3.3.242
Funatogawa I, Funatogawa T, Yano E. Trends in smoking and lung cancer mortality in Japan, by birth cohort, 1949-2010. Bull World Health Organ. 2013;91:332-340. doi:10.2471/blt.12.108092
Tangcharoensathien V, Witthayapipopsakul W, Panichkriangkrai W, Patcharanarumol W, Mills A. Health systems development in Thailand: A Solid Platform for Successful Implementation of Universal Health Coverage. Lancet. 2018;391:205-223. doi:10.1016/s0140-6736(18)30198-3
Starfield B, Shi L, Macinko J. Contribution of primary care to health systems and health. The Milbank Quarterly. 2005;83:457-502. doi:10.1111/j.1468-0009.2005.00409.x
Bundhamcharoen K, Aungkulanon S, Makka N, Shibuya K. Economic burden from smoking-related diseases in Thailand. Tob Control. 2016;25. doi:10.1136/tobaccocontrol-2015-052319
Visaruthvong C. Thailand tobacco tax report card. Bangkok, Thailand: Southeast Asia Tobacco Control Alliance; 2010.
Aminde LN, Takah NF, Zapata-Diomedi B, Veerman JL. Primary and secondary prevention interventions for cardiovascular disease in low-income and middle-income countries: a systematic review of economic evaluations. Cost Eff Resour Alloc. 2018;16:22. doi:10.1186/s12962-018-0108-9
Sreeramareddy CT, Harper S, Ernstsen L. Educational and wealth inequalities in tobacco use among men and women in 54 low-income and middle-income countries. Tob Control. 2018;27:26-34. doi:10.1136/tobaccocontrol-2016-053266
Pongpirul K, Walker DG, Winch PJ, Robinson C. A qualitative study of DRG coding practice in hospitals under the Thai universal coverage scheme. BMC Health Serv Res. 2011;11:71. doi:10.1186/1472-6963-11-71
Maciosek MV, Xu X, Butani AL, Pechacek TF. Smoking-attributable medical expenditures by age, sex, and smoking status estimated using a relative risk approach. Prev Med. 2015;77:162-167. doi:10.1016/j.ypmed.2015.05.019